Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion

Total article views   HTML views PDF downloads Totals
5,513 Dovepress* 5,513+ 2,036 7,549
Totals 5,513 2,036 7,549
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar